Anticoagulation Therapy by Age and Embolic Risk for Nonvalvular Atrial Fibrillation in Mexico, an Upper-Middle-Income Country: The CARMEN-AF Registry

Anticoagulation Therapy by Age and Embolic Risk for Nonvalvular Atrial Fibrillation in Mexico, an Upper-Middle-Income Country: The CARMEN-AF Registry

Background: Documenting the patterns of oral anticoagulation therapy (OAT) is essential to prevent thromboembolic complications of nonvalvular atrial fibrillation (NVAF). Objective: To report the patterns of OAT according to age and thromboembolic risk in patients included in CARMEN-AF, a nationwide...

Full description

Bibliographic Details
Main Authors: Manlio F. Márquez, Manuel A. Baños-González, Milton E. Guevara-Valdivia, Jorge Vázquez-Acosta, Manuel O. de los Ríos Ibarra, Julio A. Aguilar-Linares, Marcelo Jiménez-Cruz, Norberto Matadamas-Hernández, Rocío Camacho-Casillas, Reynaldo Magaña-Magaña, Ulises Rojel-Martínez, Marco A. Alcocer-Gamba, Susano Lara-Vaca, Humberto Rodríguez-Reyes, Marco A. Islava-Gálvez, Lidia E. Betancourt-Hernández, Nicolás Reyes-Reyes, Miguel E. Beltrán-Gámez, Carlos Cantú-Brito, Alberto Z. Baños-Velasco, Pedro J. del Rivero Morfin, J. Antonio González-Hermosillo
Format: Article
Language:English
Published: Ubiquity Press 2020-04-01
Series:Global Heart
Subjects:
atrial fibrillation
embolic risk
anticoagulation therapy
antithrombotic treatment
vitamin k antagonist
direct oral anticoagulant
mexico
Online Access:https://globalheartjournal.com/articles/767

Similar Items

Similar Items